PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7613528-9	1995	Liquid hybridization and Northern blotting assays revealed drug-specific regulation of the angiotensinogen mRNA level in the adrenal gland, with cilazapril producing the most marked stimulation of adrenal angiotensinogen gene expression.	Cilazapril	145-155	angiotensinogen	Rattus norvegicus	91-106	
7613528-9	1995	Liquid hybridization and Northern blotting assays revealed drug-specific regulation of the angiotensinogen mRNA level in the adrenal gland, with cilazapril producing the most marked stimulation of adrenal angiotensinogen gene expression.	Cilazapril	145-155	angiotensinogen	Rattus norvegicus	205-220	
7613528-10	1995	Both lisinopril and cilazapril suppressed hypothalamic angiotensinogen mRNA.	Cilazapril	20-30	angiotensinogen	Rattus norvegicus	55-70	
7614507-2	1995	Angiotensin II may contribute to lung vascular remodeling in pulmonary hypertensive disease, since cilazapril, an inhibitor of ACE, reduces pulmonary vascular medical thickening in chronically hypoxic rats with established pulmonary hypertension.	Cilazapril	99-109	angiotensinogen	Rattus norvegicus	0-14	
2965632-12	1988	Superimposed administration of either angiotensin II or angiotensin III during cilazapril infusion completely reversed the blood pressure and bilateral renal responses of cilazapril in both hypertensive and normotensive rats.	Cilazapril	79-89	angiotensinogen	Rattus norvegicus	38-52	
2965632-12	1988	Superimposed administration of either angiotensin II or angiotensin III during cilazapril infusion completely reversed the blood pressure and bilateral renal responses of cilazapril in both hypertensive and normotensive rats.	Cilazapril	171-181	angiotensinogen	Rattus norvegicus	38-52	
2965632-14	1988	These results indicate that cilazapril reduces arterial pressure and enhances renal excretion mainly via inhibition of angiotensin II and angiotensin III formation.	Cilazapril	28-38	angiotensinogen	Rattus norvegicus	119-133	
10446934-12	1999	Human and rat renin and angiotensinogen genes were downregulated in dTGR and were increased by losartan and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.	Cilazapril	108-118	angiotensinogen	Rattus norvegicus	24-39	
9314843-6	1997	Both cilazapril (angiotensin II-converting enzyme inhibitor) and E4177 (angiotensin II type 1 [AT1] receptor antagonist) significantly suppressed the phosphorylation of Tyk2 and partially inhibited the phosphorylation of JAK2, but neither affected JAK1.	Cilazapril	5-15	angiotensinogen	Rattus norvegicus	17-31	
2532469-7	1989	Further studies are required to determine whether this effect of cilazapril was due to the decrease of arterial blood pressure or to an effect of cilazapril on growth factors such as angiotensin II.	Cilazapril	146-156	angiotensinogen	Rattus norvegicus	183-197	
2977443-1	1988	Previous studies have shown that atrial natriuretic factor (ANF) inhibits renin secretion whereas cilazapril blocks angiotensin II generation via converting enzyme inhibition.	Cilazapril	98-108	angiotensinogen	Rattus norvegicus	116-130	
2468061-3	1988	Cilazapril is a new long-lasting inhibitor of angiotensin-converting enzyme which suppresses the peripheral vasoconstrictor effect of angiotensin I by inhibiting its transformation in angiotensin II.	Cilazapril	0-10	angiotensinogen	Rattus norvegicus	184-198